Compare Agilent Technologies Inc (A) vs Baidu Inc (BIDU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Agilent Technologies Inc vs Baidu Inc — how do they compare? Agilent Technologies Inc trades at $149.35 (market cap $42.00B), while Baidu Inc trades at $104.05 (market cap $37.11B). The key difference: Agilent Technologies Inc and Baidu Inc are close in size by market cap, and Agilent Technologies Inc pays a 0.69% dividend while Baidu Inc pays none. Which is the better fit depends on your goals.
| A | BIDU | |
|---|---|---|
Market Cap | $42.00B | $37.11B |
Sector | Health | Media |
52-Week High | $157.20 | $162.52 |
52-Week Low | $110.24 | $86.76 |
Enterprise Value | $43.55B | $33.74B |
Dividend Yield | 0.69% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $145.97, up 3.28% in the last session, with a bullish technical outlook from moving averages but overbought RSI levels. The company reported strong Q1 2026 earnings, beating estimates with EPS of $1.49, and maintains solid profitability with a net income margin of 19.55%. Recent developments include FDA and EU approvals for diagnostic assays and the acquisition of Biocare Medical, enhancing its healthcare portfolio.
The stock offers upside to the consensus price target of $154.90, supported by analyst optimism (77.5% buy ratings), but high valuation ratios like a P/E of 146.56 pose risks. Investors should monitor execution of growth initiatives and competitive pressures in the life sciences sector, with earnings on August 26, 2026, as a key catalyst.
Baidu (BIDU) trades at $109.71, up 0.35% on the day, with a neutral technical signal and bearish moving averages. Recent earnings show a Q1 2026 miss after two prior beats, while revenue declined to $129.08B in 2025. The stock is supported by strong analyst consensus (75% buy ratings) and a $169.80 price target, but faces headwinds from negative operating cash flow and competitive pressures in AI and advertising.
The outlook hinges on AI monetization and Q2 2026 results due August 18. Upside exists if Baidu leverages partnerships with Apple and Lyft, but risks include margin compression and regulatory scrutiny in China. Valuation metrics like P/E of 78.19 suggest high expectations, making execution critical for near-term performance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Agilent Technologies Inc
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →About Baidu Inc
Baidu, Inc. operates an Internet search engine. The Company offers algorithmic search, enterprise search, news, MP3, and image searches, voice assistance, online storage, and navigation services. Baidu serves clients globally.
Read more on BIDU →
